Lymphopenia: Clinical Trials

1 trial for Lymphopenia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Active not recruiting 1

Follow Lymphopenia: new trials by email Literature Review of Lymphopenia trials Research Report on Lymphopenia

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Study to Evaluate the Use of a Cryopreserved Formulation of OTL-103 in Subjects With Wiskott-Aldrich Syndrome
OTL-103 - Wiskott-Aldrich Syndrome
Phase 3Active not recruitingFondazione Telethon102019-01-212025-09-29

Narrower conditions

Wiskott-Aldrich Syndrome (1)

Broader conditions

Blood Coagulation Disorders (1)  ·  Blood Coagulation Disorders, Inherited (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Cytopenia (1)  ·  Genetic Diseases, Inborn (1)  ·  Genetic Diseases, X-Linked (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Hemorrhagic Disorders (1)  ·  Immune System Diseases (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Leukocyte Disorders (1)  ·  Leukopenia (1)  ·  Primary Immunodeficiency Diseases (1)

Sponsors

Fondazione Telethon (1)

Countries

Italy (1)  ·  United States (1)

Results publications

PMID 38446574, PMID 42777242

NIH funding

2018 (1)